CXCL10 alters the tumour immune microenvironment and disease progression in a syngeneic murine model of high-grade serous ovarian cancer.

MLA

K Au, Katrina, et al. “CXCL10 Alters the Tumour Immune Microenvironment and Disease Progression in a Syngeneic Murine Model of High-Grade Serous Ovarian Cancer.” Gynecologic Oncology, vol. 145, no. 3, June 2017, pp. 436–45. EBSCOhost, https://doi.org/10.1016/j.ygyno.2017.03.007.

APA

K Au, K., Peterson, N., Truesdell, P., Reid-Schachter, G., Khalaj, K., Ren, R., Francis, J.-A., Graham, C. H., Craig, A. W., & Koti, M. (2017). CXCL10 alters the tumour immune microenvironment and disease progression in a syngeneic murine model of high-grade serous ovarian cancer. Gynecologic Oncology, 145(3), 436–445. https://doi.org/10.1016/j.ygyno.2017.03.007

Chicago

K Au, Katrina, Nichole Peterson, Peter Truesdell, Gillian Reid-Schachter, Kasra Khalaj, Runhan Ren, Julie-Ann Francis, Charles H Graham, Andrew W Craig, and Madhuri Koti. 2017. “CXCL10 Alters the Tumour Immune Microenvironment and Disease Progression in a Syngeneic Murine Model of High-Grade Serous Ovarian Cancer.” Gynecologic Oncology 145 (3): 436–45. doi:10.1016/j.ygyno.2017.03.007.